DOYLE MITTIE (Chief Medical Officer) sold 52.3% of their position (3.97K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $71.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/8/2026ACC: 0001918845-26-000008
Officer· Chief Medical Officer
Since Feb 2026
-3.97K
Net shares
Net seller
$71.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.97K acquired · 7.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.97K
Price / share
$12.65
Trade value
$50.22K
% of position
109.6%
4/6/2026
3.62K→7.59K
Common Stock
Direct
Shares
−3.97K
Price / share
$18.01
Trade value
$71.51K
% of position
52.3%
4/6/2026
7.59K→3.62K
Total
Net shares
+0.00
Net value
-$21.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | M · Option Exercise | +3.97K | $12.65 | $50.22K | 109.6% | 3.62K | 7.59K |
| Common Stock Direct | 4/6/2026 | S · Sale | −3.97K | $18.01 | $71.51K | 52.3% | 7.59K | 3.62K |
| Total | +0.00 | -$21.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.97K shares
Shares
−3.97K
Strike price
12.65
Held after
210.53K
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.97K shares | 4/6/2026 | M · Option Exercise | −3.97K | 12.65 | — | 210.53K |